Detalles de la búsqueda
1.
Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort.
Infect Dis Ther
; 12(12): 2807-2817, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37966701
2.
Long-Term suppression of HIV infection: benefits and limitations of current treatment options.
J Assoc Nurses AIDS Care
; 18(1 Suppl): S2-10, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17275719
3.
Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment.
BMC Infect Dis
; 5: 2, 2005 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-15647105
4.
Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study.
Clin Infect Dis
; 38(2): 263-70, 2004 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-14699460
5.
Abacavir expanded access program for adult patients infected with human immunodeficiency virus type 1.
Clin Infect Dis
; 34(4): 535-42, 2002 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-11797183
6.
Once-daily versus twice-daily lamivudine, in combination with zidovudine and efavirenz, for the treatment of antiretroviral-naive adults with HIV infection: a randomized equivalence trial.
Clin Infect Dis
; 39(3): 411-8, 2004 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15307010
7.
Lamivudine 300 mg QD versus continued lamivudine 150 mg BID with stavudine and a protease inhibitor in suppressed patients.
HIV Clin Trials
; 3(5): 361-70, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12407485
8.
Efficacy, safety, and tolerability of etravirine with and without darunavir/ritonavir or raltegravir in treatment-experienced patients: analysis of the etravirine early access program in the United States.
J Acquir Immune Defic Syndr
; 53(5): 614-8, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20134329
9.
Comparison of once-daily fosamprenavir boosted with either 100 or 200 mg of ritonavir, in combination with abacavir/lamivudine: 96-week results from COL100758.
AIDS Res Hum Retroviruses
; 25(4): 395-403, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19320570
10.
Resultados
1 -
10
de 10
1
Próxima >
>>